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Summary
Mycobacterium tuberculosis and Corynebacterium
glutamicum share a similar cell wall structure and
orthologous enzymes involved in cell wall assembly.
Herein, we have studied C. glutamicum NCgl1505,
the orthologue of putative glycosyltransferases
Rv1459c from M. tuberculosis and MSMEG3120 from
Mycobacterium smegmatis. Deletion of NCgl1505
resulted in the absence of lipomannan (Cg-LM-A),
lipoarabinomannan (Cg-LAM) and a multi-manno-
sylated polymer (Cg-LM-B) based on a 1,2-di-O-C16/
C18:1-(a-D-glucopyranosyluronic acid)-(1,3)-glycerol
(GlcAGroAc2) anchor, while syntheses of triacylated-
phosphatidyl-myo-inositol dimannoside (Ac1PIM2)
and Man1GlcAGroAc2 were still abundant in
whole cells. Cell-free incubation of C. glutamicum
membranes with GDP-[14C]Man established that
C. glutamicum synthesized a novel a(1,6)-linked
linear form of Cg-LM-A and Cg-LM-B from Ac1PIM2
and Man1GlcAGroAc2 respectively. Furthermore, dele-
tion of NCgl1505 also led to the absence of in vitro
synthesized linear Cg-LM-A and Cg-LM-B, demon-
strating that NCgl1505 was involved in core a(1,6)
mannan biosynthesis of Cg-LM-A and Cg-LM-B,
extending Ac1PI[14C]M2 and [14C]Man1GlcAGroAc2
primers respectively. Use of the acceptor a-D-Manp-
(1,6)-a-D-Manp-O-C8 in an in vitro cell-free assay
conﬁrmed NCgl1505 as an a(1,6) mannopyranosyl-
transferase, now termed MptB. While Rv1459c and
MSMEG3120 demonstrated similar in vitro a(1,6)
mannopyranosyltransferase activity, deletion of the
Rv1459c homologue in M. smegmatis did not result in
loss of mycobacterial LM/LAM, indicating a functional
redundancy for this enzyme in mycobacteria.
Introduction
The taxon Corynebacterineae belongs to the Actino-
mycetes family which includes human pathogens, such as
Mycobacterium tuberculosis, Mycobacterium leprae and
Corynebacterium diphtheriae, the causal agents of tuber-
culosis, leprosy and diphtheria respectively (Coyle and
Lipsky, 1990; Bloom and Murray, 1992). Some animal
pathogens, for instance, Corynebacterium pseudotuber-
culosis and Corynebacterium matruchotii (Coyle and
Lipsky, 1990; Funke et al., 1997; Stackebrandt et al.,
1997), also belong to the Corynebacterianeae. In addi-
tion, the family member Corynebacterium glutamicum is
widely used for the industrial production of amino acids
(Eggeling and Bott, 2005). These bacilli share a unique
cell wall ultra-structure that is composed of a mycolyl-
arabinogalactan-peptidoglycan (mAGP) complex (Daffé
et al., 1990; McNeil et al., 1990; 1991; Besra et al., 1995;
Brennan, 2003; Dover et al., 2004). The esteriﬁed myco-
lates of the mAGP complex are considered to be packed
side by side and are intercalated by lipids and glycolipids.
This combined lipid structure gives rise to an asymmetric
bilayer critical for the survival of these organisms (Minni-
kin et al., 2002).
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such as phosphatidyl-myo-inositol (PI) mannosides
(PIMs) and lipoglycans, termed lipomannan (LM) and
lipoarabinomannan (LAM), are also found in this outer
leaﬂet (Hill and Ballou, 1966; Brennan and Ballou, 1967;
1968; Brennan and Nikaido, 1995; Besra et al., 1997;
Morita et al., 2004). However, LM and LAM possess
important physiological functions, and play key roles in
the modulation of the host response during infection
(Schlesinger et al., 1994; Chatterjee and Khoo, 1998;
Nigou et al., 2002; Maeda et al., 2003). The modulation
of the immune response by LAM has been attributed to
its terminal-capping motif (Nigou et al., 2002; 2003). Dif-
ferent permutations of LAM capping have been found in
Mycobacterium strains, including ManLAM (Chatterjee
et al., 1993; Khoo et al., 1995), PILAM (Gilleron et al.,
1997) and (non-capped) LAM (Guerardel et al., 2002).
Slow-growing mycobacteria, such as M. tuberculosis and
M. leprae, produce ManLAM, which enables them to
infect macrophages and dendritic cells (Schlesinger
et al., 1994; Tascon et al., 2000). ManLAM inhibits the
production of proinﬂammatory cytokines, such as IL-12
and TNF-a and inhibits phagosomal maturation (Knutson
et al., 1998; Nigou et al., 2002; Fratti et al., 2003), while
PILAM from the non-pathogenic fast-growing Mycobac-
terium smegmatis strain induces the proliferation of
these cytokines (Adams et al., 1993; Gilleron et al.,
1997).
The current model of lipoglycan biosynthesis follows
a linear pathway, PI→PIM→LM→LAM (Besra and
Brennan, 1997) (Fig. 1). PI is glycosylated by an
a-mannopyranosyl (Manp) residue catalysed by PimA
(Rv2610c), which transfers Manp from GDP-mannose to
the 2-position of PI to form PIM1 (Kordulakova et al.,
2002). PIM1 is further glycosylated by PimB (Rv0557),
which may occur before, or after acylation of PIM1 by
Rv2611c (Kordulakova et al., 2003) and results in the
formation of Ac1PIM2 (Schaeffer et al., 1999). However,
recently, this second mannosylation step in the biosyn-
thesis of Ac1PIM2 has now been shown to be catalysed
by PimB′ (Rv2188c, NCgl2106), while PimB (Rv0557,
NCgl0452), now termed MgtA, is involved in synthesiz-
ing a novel mannosylated glycolipid, 1,2-di-O-C16/C18:1-
(a-D-mannopyranosyl)-(1→4)-(a-D-glucopyranosyluronic
acid)-(1→3)-glycerol (Man1GlcAGroAc2) (Tatituri et al.,
2007; Lea-Smith et al., 2008; Mishra et al., 2008).
The analysis of deletion mutants of NCgl0452 and
NCgl2106 established that this glycolipid is further
modiﬁed to produce a multi-mannosylated derivative,
Man12-20GlcAGroAc2 (Cg-LM-B) which is coincident on
SDS-PAGE with PI-based Cg-LM, which is now termed
Cg-LM-A (Tatituri et al., 2007; Lea-Smith et al., 2008;
Mishra et al., 2008). Previous studies have shown that
RvD2-ORF1 from M. tuberculosis CDC1551, designated
as PimC, catalysed further a-mannosylation of Ac1PIM2
resulting in Ac1PIM3 (Kremer et al., 2002). Recently,
PimE (Rv1159) has been shown to be involved in higher
PIM biosynthesis and directly in the biosynthesis of
Ac1PIM5 (Morita et al., 2006); however, the enzyme
responsible for the synthesis of Ac1PIM4 from Ac1PIM3
remains to be identiﬁed.
The point at which lipoglycan biosynthesis continues
probably occurs after Ac1PIM2 and Man1GlcAGroAc2 in C.
glutamicum (Gibson et al., 2003; Tatituri et al., 2007;
Mishra et al., 2008), where a transition occurs from
glycosyltransferases which utilize nucleotide sugars
(i.e. GDP-Man) as substrate to glycosyltransferases which
utilize polyprenyl-phosphate sugars (i.e. polyprenyl-
phosphomannose, PPM) and which belong to the GT-C
superfamily, and are membrane-bound (Liu and Mush-
egian, 2003). Recently, we (Mishra et al., 2007)
and others (Kaur et al., 2007) reported a novel a-
mannosyltransferase, MptA (Rv2174), involved in the
Fig. 1. Schematic representation of the current understanding
of the LM and LAM biosynthetic pathway in M. tuberculosis.
ManT, mannosyltransferase; AraT, arabinosyltransferase; PPM,
polyprenyl-1-monophosphorylmannose; DPA, decaprenyl-1-
monophosphoryl-arabinose; R1, R2 and R3 represent acyl groups.
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Cg-LM-B biosynthesis in Corynebacterineae. The core
mannan backbone is further glycosylated by Rv2181 and
results in the synthesis of a(1→2)-Manp-linked branches,
characteristic of the mannan backbone in LM and LAM
(Kaur et al., 2006). The mature LM is then elaborated with
arabinose by the essential arabinofuranosyltransferase
EmbC (G.S. Besra, unpubl. res.) to form LAM (Berg et al.,
2005). Recently, a novel mannosyltransferase, Rv1635c
(and MT1671), has been shown to add terminal Manp
residues to the mature LAM in M. tuberculosis to form
ManLAM (Dinadayala et al., 2006; Appelmelk et al.,
2007). However, the enzyme involved in the early stages
of linear LM/LAM mannan core biosynthesis through an
a(1→6) mannosyltransferase prior to MptA remains to be
identiﬁed (Fig. 1).
In this study, we have examined the function of
C. glutamicum NCgl1505, and its orthologous genes
Rv1459c of M. tuberculosis and MSMEG3120 of M.
smegmatis encoding a putative GT-C glycosyltrans-
ferase. The NCgl1505 gene and its orthologues based
on the results described below have been designated as
mptB, as an acronym for mannopyranosyltransferase B.
Null mutants of C. glutamicum together with in vitro cell-
free assays established that NCgl1505 is a key a(1→6)
mannosyltransferase involved in the initiation of core
mannanbiosynthesisofCg-LM-AandCg-LM-BfromCoryne-
bacterineae extending Ac1PIM2 and Man1GlcAGroAc2
respectively. In addition, the M. tuberculosis orthologue
Rv1459c and M. smegmatis MSMEG3120 demonstrated
a(1→6) mannosyltransferase activity in a membrane-
based in vitro assay when utilizing a C. glutamicumD-
mptBDmptA double mutant complemented with either
plasmid-encoded Rv1459c or MSMEG3120. Finally,
using a M. smegmatis null mutant of MSMEG3120, we
also demonstrate that the mycobacterial orthologue of
NCgl1505 is functionally redundant.
Results
Genome locus and structural features of
Rv1459c/NCgl1505
Glycosyltransferases belonging to the GT-C superfamily
have been shown by us (Alderwick et al., 2005; Alderwick
et al., 2006b; Mishra et al., 2007; Seidel et al., 2007)
and others (Dinadayala et al., 2006; Kaur et al., 2006;
2007; Morita et al., 2006) to play important roles in the
biosynthesis of the cell wall heteropolysaccharides
arabinogalactan (AG), LM-A, LM-B and LAM in Coryne-
bacterinaeae. Our attention was recently drawn to a puta-
tive glycosyltransferase encoded by M. tuberculosis
Rv1459c and C. glutamicum NCgl1505, which are
members of the GT-C family of glycosyltransferases.
Orthologues of these genes are present in all Mycobac-
terium and Corynebacterium species as well as the
sequenced Nocardia farcinica IFM 10152 and Rhodococ-
cus sp. RHA1 strains (Fig. 2A). In addition, this gene is
retained in M. leprae, supporting the hypothesis that
NCgl1505 encodes for a protein possessing a vital func-
tion inherent to this group of bacteria.
The glycosyltransferase encoded by NCgl1505 is a
polytopic membrane protein, which is comprised of 558
amino acid (aa) residues, and is predicted to encode 15
hydrophobic segments (HSs) (Fig. 2B). Rv1459c consti-
tutes 591 aa, with the additional length mostly due to an
extended loop between HSs 7 and 8. This loop exten-
sion is not present in Mycobacterium paratuberculosis or
M. smegmatis. It contains a number of repeated Pro and
Arg residues, and similarly highly charged repeat
sequences are found in loop regions of other transport-
ers, without having a speciﬁc function (Eng et al., 1998;
Vrljic et al., 1999). The sequence identity of the ortho-
logues NCgl1505 and Rv1459c is 37% (52% similarity)
and can therefore be considered very high. The stron-
gest conserved regions are found in loops connecting
HSs and adjacent regions with intermediate hydropho-
bicity, like those between HSs 3–4, HSs 7–8 and HSs
13–14 (Fig. 2B). Within the highest conserved regions;
ﬁve of the six fully conserved acidic Asp and Glu resi-
dues are located, given as D and E in Fig. 2B, which are
known to play important roles as general bases and
nucleophiles in enzyme catalysis. They are also retained
in the MptB orthologue in N. farcinica IFM 10152 and
Rhodococcus sp. RHA1 are therefore likely to be
involved in catalysis, or in interactions with the sugar
donor or acceptor (Liu and Mushegian, 2003). Interest-
ingly, among the glycosyltransferases of M. tuberculosis
and C. glutamicum previously identiﬁed (Alderwick et al.,
2006a; Dinadayala et al., 2006; Kaur et al., 2006; Morita
et al., 2006; Seidel et al., 2007), NCgl1505 and Rv1459c
possess the highest identities to the recently identiﬁed
mannosyltransferase MptA (Kaur et al., 2007; Mishra
et al., 2007) and, based on the results described below,
the NCgl1505 gene and its orthologues have been des-
ignated as MptB.
Construction and growth of C. glutamicumDmptB and
complemented strains
In order to delete mptB in C. glutamicum, the non-
replicative plasmid pK19mobsacBDmptB was constructed
carrying sequences adjacent to Cg-mptB. Using this
vector, C. glutamicum was transformed to kanamycin
resistance, indicating integration of the vector into the
genome by homologous recombination (Fig. 2C). The
sacB gene enables for selection of loss of vector in
a second homologous recombination event, which can
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or in clones deleted of Cg-mptB. Ninety clones exhibiting
the desired phenotype of vector loss (kanamycin-
sensitive, sucrose-resistant) were analysed by PCR, but
only one single colony was found to have Cg-mptB
excised, whereas the others resulted in a wild-type
genotype. The low number of recombinant knockouts indi-
cates that the loss of Cg-mptB is apparently a disadvan-
tage for cell viability, similar to that of previously observed
mutants with altered mycolate (Gande et al., 2004) or
arabinogalactan biosynthesis (Alderwick et al., 2006b).
The resulting clone was subsequently termed C. glutamic-
umDmptB and conﬁrmed by PCR with different primer
pairs to have Cg-mptB deleted, whereas controls with
C. glutamicum wild type resulted in the expected larger
ampliﬁcation product (Fig. 2C).
In liquid culture, growth of C. glutamicumDmptB was
very poor. Only when rich brain heart infusion (BHI)
medium was used was a growth rate of 0.13 h-1 obtained
(Fig. 2D) in comparison with wild-type C. glutamicum
growth rate of 0.31 h-1 (Mishra et al., 2007) and, on the
same medium supplemented with 500 mM sorbitol
(BHIS), the growth rate was 0.51 h-1, which is still lower
than that of the wild type on this medium (0.70 h-1). C.
glutamicumDmptB was transformed with pVWEx-Cg-
mptB and the resultant complemented strain exhibited a
growth rate of 0.66 h-1, almost superimposable to that of
the wild type in BHIS medium.
Fig. 2. Generation of an in-frame deletion mutant of C. glutamicum mptB.
A. The locus in the bacteria analysed consists of mptB which has in C. glutamicum the locus tag NCgl1505 and in M. tuberculosis Rv1459c.
sufR encodes a transcriptional regulator in front of an operon of the SUF machinery of [Fe-S] cluster synthesis (Huet et al., 2006). The
genomic region displayed encompasses 7 kb, and orthologous genes are highlighted accordingly. Nocardia farcina, Nocardia farcina IFM
10152; Rhodococcus, Rhodococcus sp. strain RHA1.
B. MptB is a hydrophobic protein predicted to span the membrane 15 times and the transmembrane helices are numbered accordingly. The
lower part of the ﬁgure shows the degree of conservation of the orthologues given in A as analysed by the DIALIGN method (Morgenstern,
2004). Also shown is the approximate position of the fully conserved aspartyl (D) and glutamyl (E) residues.
C. Strategy to delete Cg-mptB using the deletion vector pK19mobsacBDmptB. This vector carries 18 nucleotides of the 5′ end of Cg-mptB and
36 nucleotides of its 3′ end, thereby enabling the in-frame deletion of almost the entire Cg-mptB gene. The arrows marked PA and PB locate
the primers used for the PCR analysis to conﬁrm the absence of Cg-mptB. Distances are not drawn to scale. The results of the PCR analysis
with the primer pair PA/PB are shown on the right. Ampliﬁcation products obtained from the wild type (wt) were applied in the middle lane and
that of the deletion mutant (D) in the left lane. ‘st’ marks the standard, where the arrowheads are located at 1.5, 1 and 0.5 kb.
D. Growth of C. glutamicum on rich BHIS (solid lines). Wild-type C. glutamicm, ﬁlled triangle; C. glutamicumDmptB, open triangle; C. glutamic-
umDmptB pVWEx-Cg-mptB, open square. Growth of C. glutamicumDmptB on rich BHI medium are the open triangles with the broken line.
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C. glutamicumDmptB
Lyophilized cells were extracted using petroleum-ether
and methanolic saline to initially recover apolar lipids.
Further processing of the methanolic extract afforded
the polar lipid fraction which was examined by two-
dimensional thin-layer chromatography (2D-TLC). In
both the wild-type C. glutamicum and C. glutamicumD-
mptB,A c 1PIM2 and Man1GlcAGroAc2 (Tatituri et al.,
2007) were visualized either by a-naphthol/sulphuric
acid (speciﬁc for sugars), 5% ethanolic molybdophos-
phoric acid (general lipid stain) (Fig. S1) or Dittmer and
Lester reagent (speciﬁc for phospholipids). In both C.
glutamicum and C. glutamicumDmptB, no products could
be observed which correspond to higher PIMs (i.e.
Ac1PIM3 through to Ac1PIM6) or higher mannose
variants of Man1GlcAGroAc2 (Tatituri et al., 2007; Mishra
et al., 2008). The presence of only Ac1PIM2 and
Man1GlcAGroAc2, and the inability to synthesize
Cg-LAM, Cg-LM-A and Cg-LM-B by C. glutamicumD-
mptB (as shown below) demonstrated that MptB is
involved in the early steps of a(1→6) mannan core bio-
synthesis by extending the substrates Ac1PIM2 and
Man1GlcAGroAc2.
Analysis of lipoglycans from C. glutamicum,
C. glutamicumDmptB and C. glutamicumDmptB
pVWEx-Cg-mptB
Lipoglycans were extracted by reﬂuxing delipidated cells
in ethanol, followed by hot-phenol extraction, protease
digestion and dialysis to remove impurities. The extracted
lipoglycans were examined initially on 15% SDS-PAGE
(Fig. 3A). Extracts from wild-type C. glutamicum showed
the presence of Cg-LAM, Cg-LM-A and Cg-LM-B with
the latter product based on previous results comigrating
with Cg-LM-A (Tatituri et al., 2007; Mishra et al., 2008),
while all of these lipoglycans were absent from C.
glutamicumDmptB. Complementation of C. glutamicumD-
mptB by transformation with plasmid pVWEx-Cg-mptB
restored the wild-type phenotype (Fig. 3A). In addition,
transformation of C. glutamicumDmptB with plasmid
pVWEx-Cg-mptA failed to restore the wild-type phenotype
(data not shown).
Construction and growth of C. glutamicumDmptADmptB
and complemented strains
As a result of the similarity of MptB with MptA, we wanted
to exclude any possible interferences and constructed a
Fig. 3. Lipoglycan proﬁle of C. glutamicum
strains analysed using SDS-PAGE and
visualized using a Pro-Q emerald glycoprotein
stain (Invitrogen) speciﬁc for carbohydrates.
A. Lipolglycans extracted from C. glutamicum,
C. glutamicumDmptB and C.
glutamicumDmptB pVWEx-Cg-mptB. The
major bands represented by Cg-LAM,
Cg-LM-A and Cg-LM-B are indicated.
B. C. glutamicum, C. glutamicumDmptB,
C. glutamicumDmptA, C.
glutamicumDmptBDmptA, C.
glutamicumDmptBDmptA pVWEx-Cg-mptB
and C. glutamicumDmptBDmptA
pVWEx-Cg-mptA. The truncated version of
Cg-LM-A/B is indicated as Cg-t-LM-A/B
(Mishra et al., 2007). The four major bands
represent glycoproteins of 180, 82, 42 and
18 kDa respectively.
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this purpose, C. glutamicumDmptB was transformed with
plasmid pK19mobsacBDmptA (Mishra et al., 2007) and
processed as described in Experimental procedures to
afford the double mutant, C. glutamicumDmptBDmptA.
Analysis of this strain showed that its growth characteris-
tics were very similar to C. glutamicumDmptB (data not
shown). For further analysis, C. glutamicumDmptADmptB
was transformed with plasmid-encoded Cg-mptB,C g -
mptA,M t - mptB and Ms-mptB.
Analysis of lipoglycans from
C. glutamicumDmptBDmptA, C. glutamicumDmptBDmptA
pVWEx-Cg-mptB and C. glutamicumDmptBDmptA
pVWEx-Cg-mptA
In addition to MptB, C. glutamicum possesses the known
a(1→6) mannosyltransferase MptA, which is involved in
the later stages of core mannan biosynthesis (Mishra
et al., 2007) and, as a result, we wanted to study the
in situ speciﬁcity of these glycosyltransferases. For this
purpose, lipoglycans were extracted from C. glutamicum-
DmptBDmptA, and from the same strain carrying either
pVWEx-Cg-mptB or pVWEx-Cg-mptA and analyzed by
15% SDS-PAGE (Fig. 3B). Extracts from C. glutamicum-
DmptBDmptA indicated that, as expected, no lipoglycans
were present, whereas the presence of pVWEx-Cg-mptB
resulted in formation of a truncated (Cg-t) version of
Cg-LM-A and Cg-LM-B (Mishra et al., 2007; 2008).
However, lipoglycan extracts from C. glutamicumDmptB-
DmptA carrying pVWEx-Cg-mptA were identical to that of
C. glutamicumDmptBDmptA, indicating that MptA fails to
substitute for MptB in the double mutant. As pVWEx-Cg-
mptA results in functional MptA (Mishra et al., 2007), this
result shows that MptA is unable to substitute in vivo for
MptB. Therefore, both MptA and MptB are distinct and
MptB is involved in the initial steps of Cg-LAM, Cg-LM-A
and Cg-LM-B biosynthesis, prior to MptA. Furthermore,
analysis of C. glutamicumDmptBDmptA carrying either
pVWEx-Mt-mptB or pVWEx-Ms-mptB resulted in a com-
plete lack of lipoglycan biosynthesis (data not shown),
indicating that Mt-MptB and Ms-MptB do not function
in vivo as the initial a(1→6) mannosyltransferase pro-
bably because of an inability to extend Ac1PIM2 and
Man1GlcAGroAc2 by mannose residues as shown below
through in vitro chase experiments.
In vitro incorporation of radiolabelled Man from
GDP-[14C]Man into membrane lipids utilizing
C. glutamicum, C. glutamicumDmptB and
complemented strains
Incorporation of [14C]Man from GDP-[14C]Man into
CHCl3/CH3OH (2:1) and CHCl3/CH3OH/H2O (10:10:3)-
soluble lipids was examined using membrane/cell
envelope extracts prepared from C. glutamicum as
described previously utilizing mycobacterial membrane/
cell envelope fractions (Besra et al., 1997). TLC
autoradiography (Fig. 4A, lane 1) of the CHCl3/CH3OH
(2:1)-soluble lipids synthesized by wild-type C.
glutamicum membrane/cell envelope extracts contained
as expected b-D-mannopyranosyl-1-monophosphoryl-
decaprenol (C50-PP[14C]M), [14C]Man1GlcAGroAc2 and
Ac1PI[14C]M2. The identity of the three labelled lipids
was established by: (i) base treatment, i.e. degradation
of Ac1PI[14C]M2 and [14C]Man1GlcAGroAc2 (Fig. 4A, lane
2), (ii) addition of amphomycin, which speciﬁcally che-
lates polyprenyl phosphates in the presence of Ca2+ and
thus inhibiting the transfer of Man from GDP-Man to
polyprenyl carriers (Fig. 4A, lane 3) and (iii) in compari-
son with known standards (Tatituri et al., 2007). As
expected from the analysis of whole cells, C. glutamic-
umDmptB synthesized comparable levels of all three
radiolabelled lipids using membrane/cell envelope
extracts prepared from C. glutamicumDmptB (Fig. 4A,
lane 4).
The above reaction mixtures were then further pro-
cessed as described in the Experimental procedures
section to provide the CHCl3/CH3OH/H2O (10:10:3)-
soluble lipids initially using membrane/cell envelope
extracts prepared from C. glutamicum to provide
[14C]mannooligosaccharides (Fig. 4B, no. 1), which were
further characterized by a series of degradation experi-
ments. The [14C]mannooligosaccharides were sensitive
to acetolysis (see Fig. 4B, no. 3), thus establishing a
core a(1→6)-linear mannan backbone within the CHCl3/
CH3OH/H2O (10:10:3)-soluble lipids. In separate ex-
periments, the addition of amphomycin to block C50-
PP[14C]M synthesis also inhibited the synthesis of the
a(1→6)-linear mannan lipids, demonstrating that the syn-
thesis of these CHCl3/CH3OH/H2O (10:10:3)-soluble
lipids is PPM-dependent (Fig. 4B, no. 2) and similar
to the previously characterized in vitro synthesized
mycobacterial products (Besra et al., 1997). SDS-
polyacrylamide gel electrophoresis and subsequent auto-
radiography of the dried gels demonstrated that the
CHCl3/CH3OH/H2O (10:10:3)-soluble lipids (Fig. 4B, no.
1) had slightly reduced mobility, indicating that they were
smaller in size (Fig. 4B, left-panel inset), presumably
because of their lack of a(1→2) branching characteristic
of Cg-LM-A and Cg-LM-B (Tatituri et al., 2007). As
expected, synthesis of CHCl3/CH3OH/H2O (10:10:3)-
soluble lipids using membranes from C. glutamicumD-
mptB was completely abolished (Fig. 4B, no. 4).
Furthermore, complementation with pVWEx-Cg-mptB
restored synthesis of CHCl3/CH3OH/H2O (10:10:3)-
soluble lipids (Fig. 4B, no. 5).
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14C]Man from GDP-[
14C]Man into corynebacterial membrane/cell envelope lipids.
A. TLC autoradiography of labelled CHCl3/CH3OH (2:1)-soluble lipids, C50-PP[
14C]M, [
14C]Man1GlcAGroAc2 and Ac1PI[
14C]M2 using
GDP-[
14C]Man and membrane/cell envelope extracts from C. glutamicum and C. glutamicumDmptB. Membrane/cell envelope fractions were
incubated with GDP-[
14C]Man in a total volume of 100 ml for 60 min in either the absence or presence of amphomycin (10 mg) and Ca
2+ ions
per reaction mixture pre-incubated with membranes for 15 min. Enzymatically synthesized products C50-PP[
14C]M, [
14C]ManGlcAGroAc2 and
Ac1PI[
14C]M2 were isolated as described in Experimental procedures to provide washed CHCl3/CH3OH (2:1)-soluble lipids and also subjected
to base treatment. Aliquots (10%) were taken for scintillation counting and the remaining products subjected to TLC/autoradiography using
CHCl3/CH3OH/NH4OH/H2O (65:25:0.4:3.6, v/v/v/v). C. glutamicum CHCl3/CH3OH (2:1)-soluble lipids (lane 1), base treatment of CHCl3/CH3OH
(2:1)-soluble lipids (lane 2), amphomycin treatment (lane 3) and C. glutamicumDmptB CHCl3/CH3OH (2:1)-soluble lipids (lane 4).
B. Characterization of CHCl3/CH3OH/H2O (10:10:3)-soluble lipids as a(1→6)-linear mannooligosaccharides. The insoluble pellet from the
above reaction mixtures following extraction with CHCl3/CH3OH (2:1) were sequentially washed with 0.9% NaCl in 50% CH3OH, 50% CH3OH
and CH3OH, prior to extraction with CHCl3/CH3OH/H2O (10:10:3) and an aliquot (10%) taken for scintillation counting and the remaining
product analysed by SDS-PAGE/autoradiography (left-panel inset). C. glutamicum (no. 1), amphomycin treatment (no. 2) and acetolysis
treatment of CHCl3/CH3OH/H2O (10:10:3)-soluble lipids (no. 3), C. glutamicumDmptB (no. 4) and C. glutamicumDmptB pVWEx-Cg-mptB
(no. 5) as described in the Experimental procedures.
C and D. Incorporation of in vitro in situ Ac1PI[
14C]M2 and [
14C]Man1GlcAGroAc2 into a(1→6)-linear mannooligosaccharides with either
C. glutamicum, C. glutamicumDmptB or C. glutamicumDmptB pVWEx-Cg-mptB membrane preparations. Membranes were initially pre-treated
with amphomycin, labelled using GDP-[
14C]Man, re-harvested by centrifugation and extensively washed with buffer. At t = 0 min, an aliquot
of membranes (20%) was processed as described in the Experimental procedures for CHCl3/CH3OH (2:1)-soluble lipids and analysed by
TLC/autoradiography using CHCl3/CH3OH/NH4OH/H2O (65:25:0.4:3.6, v/v/v/v) (C) and CHCl3/CH3OH/H2O (10:10:3)-soluble lipids by
SDS-PAGE/autoradiography (D). The carefully washed [
14C]-labelled membranes were re-incubated for a further 60 min following the addition
of 0.5 mg cold C50-PPM (Gurcha et al., 2002). At t = 60 min, an equivalent membrane aliquot as based on t = 0 was again analysed for
CHCl3/CH3OH (2:1) and CHCl3/CH3OH/H2O (10:10:3)-soluble lipids as described above (C and D).
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[14C]Man1GlcAGroAc2 into a(1,6)-linear Cg-LM-A and
Cg-LM-B utilizing membranes from C. glutamicum,
C. glutamicumDmptB and C. glutamicumDmptB
complemented strains
Amphomycin-treated wild-type C. glutamicum membrane/
cell envelope extracts were initially pulsed with GDP-
[14C]Man during a short incubation period (15 min) which
was shown earlier to inhibit the synthesis of the CHCl3/
CH3OH/H2O (10:10:3)-soluble a(1→6)-linear [14C]mannan
lipids but, instead of extracting with CHCl3/CH3OH (2:1),
the [14C]Man-labelled membranes were re-harvested
by ultracentrifugation at 100 000 g, carefully washed and
re-centrifuged twice using cold buffer, to remove unused
GDP-[14C]Man. An aliquot of the [14C]Man-labelled mem-
branes were extracted with CHCl3/CH3OH (2:1) and con-
tained as expected solely Ac1PI[14C]M2 (3329 c.p.m.) and
[14C]Man1GlcAGroAc2 (5474 c.p.m.) at t = 0 chase time as
determined by TLC autoradiography and phosphorimag-
ing (Fig. 4C). The CHCl3/CH3OH/H2O (10:10:3)-soluble
lipids at t = 0 gave 226 c.p.m.The [14C]Man-labelled mem-
branes were then further incubated for 60 min following
the addition of excess exogenous cold C50-PPM (Gurcha
et al., 2002) prior to the standard extraction method
to provide CHCl3/CH3OH (2:1) and CHCl3/CH3OH/H2O
(10:10:3)-soluble lipids. The t = 60 chase time revealed a
loss of radioactivity from both Ac1PI[14C]M2 (1709 c.p.m.)
and [14C]Man1GlcAGroAc2 (2530 c.p.m.) as determined by
TLC autoradiography and phosphorimaging, and incorpo-
ration into CHCl3/CH3OH/H2O (10:10:3)-soluble a(1→6)-
linear [14C]mannooligosaccharide lipids (2895 c.p.m.)
(Fig. 4D). The in vitro in situ chase experiment demon-
strated that the a(1→6)-linear [14C]mannooligosaccharide
lipids synthesized were elongation products of both
Ac1PI[14C]M2 and [14C]Man1GlcAGroAc2. Similar experi-
ments repeated with C. glutamicumDmptB in situ prepared
[14C]-labelled membranes as above resulted in com-
parable products at t = 0 and t = 60 for CHCl3/CH3OH
(2:1)-soluble lipids [Ac1PI[14C]M2 (t = 0, 3345 c.p.m.;
t = 60, 2968 c.p.m.) and [14C]Man1GlcAGroAc2 (t = 0,
5840 c.p.m.; t = 60, 5025 c.p.m.)] and a lack of the syn-
thesis of a(1→6)-linear [14C]mannooligosaccharide lipids
(240 c.p.m.) from the elongation primersAc1PI[14C]M2 and
[14C]Man1GlcAGroAc2 following the ‘chase period’(Fig. 4C
and D). Complementation of C. glutamicumDmptB by
transformation with plasmid pVWEx-Cg-mptB resulted
in Ac1PI[14C]M2 (t = 0, 3229 c.p.m.; t = 60, 1725 c.p.m.)
and [14C]Man1GlcAGroAc2 (t = 0, 5367 c.p.m.; t = 60,
2550 c.p.m.) and in vitro in situ synthesis of a(1→6)-linear
[14C]mannooligosaccharide lipids (2471 c.p.m.) to levels
comparable to wild type C. glutamicum (Fig. 4C and D).
The data clearly demonstrate that Cg-MptB functions
in vivo and in vitro as the initial a-mannosyltransferase,
which extends Ac1PIM2 and Man1GlcAGroAc2. However,
under the same in vitro in situ chase conditions, C.
glutamicumDmptB pVWEx-Mt-mptB (or pVWEx-Ms-mptB)
failed to elongate the primers Ac1PI[14C]M2 and
[14C]Man1GlcAGroAc2 and restore synthesis of the
a(1→6)-linear [14C]mannooligosaccharides (data not
shown). In addition, experiments conducted with C.
glutamicumDmptB pVWEx-Mt-mptB and C. glutamicumD-
mptB pVWEx-Ms-mptB and the addition of the exogenous
primer Ac1PI[14C]M4 isolated from a M. bovis BCG PimE
mutant also failed to restore the synthesis of the a(1→6)-
linear [14C]mannooligosaccharides (data not shown).
In vitro analysis of a(1,6) mannosyltransferase activity
using C. glutamicumDmptB, C. glutamicumDmptBDmptA
and complemented strains
Initial attempts to develop an in vitro assay using either
puriﬁed recombinant-expressed MptB, or Escherichia coli
membranes harbouring the protein, have thus far proved
unsuccessful. Alternatively, we assessed the capacity
of membrane preparations from C. glutamicum and its
recombinant strains to catalyse a(1→6) mannosyltrans-
ferase activity in a previously deﬁned acceptor assay uti-
lizing the neoglycolipid acceptor a-D-Manp-(1→6)-a-D-
Manp-O-C8 and C50-PP[14C]M as a sugar donor (Brown
et al., 2001) (Fig. 5A). The TLC autoradiography of prod-
ucts from in vitro assays when assayed with wild-type
C. glutamicum resulted in the formation of product X,
a trisaccharide a-D-[14C]Manp-(1→6)-a-D-Manp-(1→6)-
a-D-Manp-O-C8, and product Y, a tetrasaccharide
a-D-[14C]Manp-(1→6)-a-D-Manp-(1→6)-a-D-Manp-(1→6)-
a-D-Manp-O-C8 (Fig. 5B). These products comigrated on
TLC autoradiography with the corresponding products
previously chemically characterized and prepared using
mycobacterial membranes, and were cleaved by acetoly-
sis, demonstrating that they were a(1→6)-linked [14C]Man
products (Fig. 5B and C) (Brown et al., 1997; 2001).
The intensity of the major product X, a trisaccharide
a-D-[14C]Manp-(1→6)-a-D-Manp-(1→6)-a-D-Manp-O-C8,
was consistently slightly reduced in the case of C.
glutamicumDmptB (89 217  4269 c.p.m.) in comparison
with wild-type C. glutamicum (92 325  5017 c.p.m.)
(Fig. 5B). This reduction in activity corresponded to the
residual a(1→6) mannosyltransferase activity observed in
C. glutamicumDmptA (2053  604 c.p.m.) (Fig. 5B)
(Mishra et al., 2007). These results suggested the pres-
ence of two a(1→6) mannosyltransferase activities utiliz-
ing this neoglycolipid acceptor, catalysed by MptA and
MptB, with the former more efficiently utilizing the neogly-
colipid acceptor as a substrate. Assays containing mem-
brane preparations from C. glutamicumDmptBDmptA
showed no product formation on TLC, indicating a com-
plete abrogation of both a(1→6) mannopyranosyltrans-
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of the double mutant with pVWEx-Cg-mptB revealed a
signiﬁcant but weak band (2682  940 c.p.m.) corre-
sponding to product X on TLC analysis; however, when
complemented with pVWEx-Cg-mptA, a similar pheno-
type to that of C. glutamicumDmptB could be observed
(80 614  4135 c.p.m. for X), although at a slower trans-
fer rate. The data conﬁrmed that NCgl1505 is an a(1→6)
mannopyranosyltransferase; however, the speciﬁc
a(1→6) mannopyranosyltransferase activity is much
lower in comparison with MptA, under the assay condi-
tions utilizing the neoglycolipid acceptor.
In vitro and mutational analysis of the
mycobacterial MptB
To study the function of the mycobacterial MptB, we trans-
formed the C. glutamicumDmptBDmptA double mutant
with a plasmid containing either M. tuberculosis Rv1459c
(pVWEx-Mt-mptB)o rM. smegmatis MSMEG3120
Fig. 5. Analysis of products obtained in a cell-free assay for detecting a(1→6) mannosyltransferase activity.
A. Biosynthetic reaction scheme of products formed in the a(1→6) mannosyltransferase assay utilizing a-D-Manp-(1→6)-a-D-Manp-O-C8 and
C50-PP[
14C]M.
B. TLC analysis of products obtained in a cell-free assay for detecting a(1→6) mannosyltransferase activity with membranes prepared from
M. smegmatis, C. glutamicum, C. glutamicumDmptB, C. glutamicumDmptA, C. glutamicumDmptBDmptA, C. glutamicumDmptBDmptA
pVWEx-Cg-mptB and C. glutamicumDmptBDmptA pVWEx-Cg-mptA.
C. TLC autoradiography of reaction products X and Y prepared with M. smegmatis and C. glutamicum membranes and subjected to acetolysis
as described in the Experimental procedures (Brown et al., 1997).
D. TLC analysis of products obtained in a cell-free assay for detecting a(1→6) mannosyltransferase activity with membranes prepared from
C. glutamicumDmptADmptB, C. glutamicumDmptADmptB pVWEx-Mt-mptB and C. glutamicumDmptADmptB pVWEx-Ms-mptB. Assays were
performed using the synthetic a-D-Manp-(1→6)-a-D-Manp-O-C8 neoglycolipid acceptor in a cell-free assay as described (Brown et al., 2001).
The products of the assay were re-suspended in n-butanol before scintillation counting. The incorporation of [
14C]Manp was determined by
subtracting counts present in control assays (incubations in the absence of acceptor), which were typically less than 100 c.p.m. per assay. The
remaining labelled material was subjected to TLC using silica gel plates (5735 silca gel 60F254, Merck) developed in CHCl3:CH3OH:H2O;
NH4OH (65:25:3.6:0.5, v/v/v/v) and the products visualized by phosphorimaging (Kodak K Screen). The results represent triplicate assays in
three independent experiments. A schematic representation of the reaction is showed in (A) and the products X and Y are indicated by
arrows.
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strains restored in vitro a(1→6) mannopyranosyltrans-
ferase activity (Fig. 5D) by formation of the trisaccharide
product X (Mt-MptB, 3159  456 c.p.m. and Ms-MptB,
2949  378 c.p.m.) to a similar level to that of the isogenic
strain with pVWEx-Cg-mptB (Fig. 5B), showing that the M.
tuberculosis and M. smegmatis gene could restore activity
in an in vitro cell-free assay with the C. glutamicum double
mutant. We then generated a null mutant of M. smegmatis
mc2155 MSMEG3120 (homologue of Rv1459c) using spe-
cialized transduction (Fig. 6A), and analysed total lipids
and lipoglycans in the mutant strain. Surprisingly, the
mutant strain DMSMEG3120 had a total lipid proﬁle iden-
tical to the parental wild-type strain M. smegmatis mc2155
(TLC system designed to separate PIMs and other phos-
pholipids is shown in Fig. 6B) and also synthesized
LM and LAM (Fig. 6C). These results suggested
that MSMEG3120, unlike its corynebacterial counter-
part, was redundant and it was likely that another
a-mannosyltransferase compensated for the loss of its
function in the DMSMEG3120 mutant.
Discussion
Over the past decade, much research has been carried
out on the mechanisms and genetics of mycobacterial cell
Fig. 6. Characterization of a M. smegmatis
mptB (MSMEG3120) mutant.
A. Map of the MSMEG3120 region in the wild
type, parental strain M. smegmatis mc
2155
and its corresponding region in the
DMSMEG3120 mutant. res, resolvase site;
hyg, hygromycin-resistance gene from
Streptomyces hygroscopicus; sacB, sucrose
counterselectable gene from Bacillus subtilis.
B. 2D-TLC analysis of the [
14C]-labelled
(50 000 c.p.m.) polar lipids fraction
from M. smegmatis (WT) and
M. smegmatisDMSMEG3120 strains.
The polar lipid extract was examined on
aluminum-backed plates of silica gel 60 F254
(Merck 5554), using CHCl3/CH3OH/H2O
(60:30:6, v/v/v) in the ﬁrst direction and
CHCl3/CH3COOH/CH3OH/H2O (40:25:3:6,
v/v/v/v) in the second direction. Lipids were
visualized by autoradiography by overnight
exposure of Kodak X-Omat AR ﬁlm to the
TLC plates to reveal labelled lipids.
C. Lipoglycan analysis of wild-type M.
smegmatis and M. smegmatisDMSMEG3120
using SDS-PAGE and visualized using a
Pro-Q emerald glycoprotein stain (Invitrogen).
The four major bands represent glycoproteins
of 180, 82, 42 and18 kDa respectively.
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of the essential AG (Daffe et al., 1993; Besra et al., 1995;
Belanger et al., 1996; Kremer et al., 2001; Alderwick
et al., 2005; 2006a,b; Berg et al., 2007; Seidel et al.,
2007) and the immunomodulatory heteropolysaccharides
LM and LAM (Schaeffer et al., 1999; Kordulakova et al.,
2002; Kremer et al., 2002; Zhang et al., 2003; Dinadayala
et al., 2006; Kaur et al., 2006; 2007; Mishra et al., 2007).
An archetypal biosynthetic pathway is now emerging for
the formation of these important macromolecules, which
predominantly include enzymes from the GT-A, B and C
superfamily of glycosyltransferases (Liu and Mushegian,
2003) (Fig. 1). PimA, PimB, PimB′ and PimC, all of which
are GT-A/B glycosyltransferases, have been shown to be
involved in PIM biosynthesis, which serves as a substrate
for LM/LAM extension and maturation (Schaeffer et al.,
1999; Kordulakova et al., 2002; Kremer et al., 2002; Lea-
Smith et al., 2008; Mishra et al., 2008). We and others
recently identiﬁed the GT-C glycosyltransferase MptA as
an a(1→6) mannosyltransferase involved in intermediate
LM biosynthesis, speciﬁcally in distal a(1→6) core LM
formation (Kaur et al., 2007; Mishra et al., 2007). Apart
from a core a(1→6) mannan backbone, a(1→2) mannose
residues punctuate LM, and the GT-C glycosyltransferase
Rv2181 has been identiﬁed to be responsible for some, if
not all, of these branched mannose residues (Kaur et al.,
2006). At some point, LM is further glycosylated by other
GT-C glycosyltransferases, such as EmbC for the biosyn-
thesis of LAM (Zhang et al., 2003) and then mannose-
capped (Dinadayala et al., 2006; Appelmelk et al., 2007).
In this study, we have characterized the role of a putative
glycosyltransferase (NCgl1505) belonging to the GT-C
superfamily of glycosyltransferases (Liu and Mushegian,
2003) by virtue of genomic deletion in C. glutamicum.W e
present MptB as a PPM-dependent a(1→6) mannosyl-
transferase, involved in early stages of proximal
a(1→6) core Cg-LM-A and Cg-LM-B biosynthesis in
C. glutamicum (Fig. 7).
Our initial in vivo and in vitro studies of PIM and
Man1GlcAGroAc2 biosynthesis in C. glutamicumDmptB
highlighted no apparent change in lipid proﬁles, compared
with those from wild-type C. glutamicum (Figs S1 and 4A).
It is reasonable to conclude from the data that MptB is
not involved in either early PIM or Man1GlcAGroAc2
Fig. 7. Schematic representation of the glycosyltransferases involved in C. glutamicum lipoglycan biosynthesis.
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synthetic steps are completely unique to enzymes belong-
ing to the GT-A/B glycosyltransferase family, which
utilize GDP-mannose as a substrate (Liu and Mushegian,
2003). Assays utilizing membrane preparations from C.
glutamicum and C. glutamicumDmptB indicated that there
was no further accumulation of higher mannosylated ver-
sions of PIMs and Man1GlcAGroAc2. The lack of higher
mannosylated versions in C. glutamicum suggests that
the next committed step in lipoglycan biosynthesis stems
fromAc1PIM2 and Man1GlcAGroAc2 and that this is cataly-
sed by Cg-MptB.
As a result of absence of MptB, C. glutamicumDmptB is
unable to synthesize Cg-LAM, Cg-LM-A and Cg-LM-B in
vivo, which is in contrast to our earlier studies on MptA,
where a truncated Cg-LM-A and Cg-LM-B species was
synthesized (Mishra et al., 2007). In C. glutamicum,w e
now also present in vitro evidence that Ac1PIM2 and
Man1GlcAGroAc2 are acceptors for Cg-MptB, the ﬁrst
GT-C a-mannosyltransferase committed to Cg-LM-A and
Cg-LM-B biosynthesis. This is supported by in vitro
in situ chase experiments elongating theAc1PI[14C]M2 and
[14C]Man1GlcAGroAc2 primers by the sugar donor C50-
PPM. These crucial observations, together with the pres-
ence of Ac1PIM2 and Man1GlcAGroAc2, completely
support our hypothesis that Cg-MptB mannosylates
Ac1PIM2 and Man1GlcAGroAc2. Our previous experiments
on glycosyltransferase activities in membranes prepared
from C. glutamicumDmptA identiﬁed a residual a(1→6)
mannosyltransferase activity (Mishra et al., 2007). This
a-mannosyltransferase activity can now be attributed to
the presence of MptB as, upon its deletion in C.
glutamicum, a partial depletion in a(1→6) mannosyltrans-
ferase activity is observed and a complete loss of activity
is found upon deletion of both Cg-mptA and Cg-mptB.
These data together with the in vivo analyses identify
MptB as a bona ﬁde a(1→6) mannosyltransferase. Inter-
estingly, a(1→6) mannan extension is more complex in
Mycobacterium based on the evidence that Mt-MptB and
Ms-MptB fail to complement the C. glutamicumDmptB
mutant and suggests a slightly different substrate speci-
ﬁcity of the MptB orthologues of M. tuberculosis and M.
smegmatis. Although, clearly a(1→6) mannosyltrans-
ferase(s) based on in vitro data, studies are currently
underway exploring heterologous protein expression
systems for Mt-MptB and Ms-MptB in combination with a
variety of substrates in a revised in vitro assay format.
Given the high degree of homology between the C.
glutamicum and mycobacterial orthologues of MptB and
the similar organization of neighbouring genes in the two
genera, we expected deletion of M. smegmatis mptB
(MSMEG3120) to have the same effect as that in C.
glutamicum. However, surprisingly, the M. smegmatis
mptB mutant still synthesised LM and LAM, indicating that
another, yet unidentiﬁed, a-mannosyltransferase could
substitute for MptB in the mutant M. smegmatis strain. It
has been previously shown that a high degree of func-
tional redundancy exists in key enzymes involved in
mycobacterial cell wall assembly, for instance, PimB/
PimB′ and MgtA (Schaeffer et al., 1999; Tatituri et al.,
2007; Lea-Smith et al., 2008; Mishra et al., 2008), PimC
(Kremer et al., 2002), and EmbA and EmbB (Berg et al.,
2007) in PIM/LM/LAM and AG biosynthesis, and the
antigen 85 complex in mycolic acid biosynthesis (Puech
et al., 2002). In this particular case, the C. glutamicum
mutant study enabled the assignment of function to the
GT-C glycosyltransferase NCgl1505, which would have
otherwise not been possible if similar studies would have
concentrated solely on mycobacterial species.
Interestingly, the mechanism of how Ac1PIM2 traverses
the cytoplasmic membrane remains poorly understood.
Bioinformatic inspection of the locus surrounding MptB
has highlighted two possible candidates for potential
ﬂippases. Downstream of the putative glycosyltransferase
Rv1459c, three conserved genes are located in all
Corynebacterinaeae and the expression of the four-gene
locus in C. glutamicum is translationally coupled (Wang
et al., 2006). This presents strong evidence for a func-
tional coupling of the putative glycosyltransferase
Rv1459c with Rv1458c, Rv1457c and Rv1456c. The latter
genes encode for twoABC transporter integral membrane
proteins, with Rv1458c encoding for an ATP-dependent
binding protein. Applying structure prediction compari-
sons and hidden Markov models (Soding et al., 2005),
Rv1458c exhibits remote structural similarities to sugar-
binding proteins of ABC carriers, such as the sugar-
binding protein of Pyrococcus horikoshii or the maltose/
maltodextrin-binding protein MALK of E. coli (Lu et al.,
2005). Rv1457c encodes a permease component of an
ABC-2-type transporter, characteristically involved in
catalysing the export of drugs and carbohydrates (Reizer
et al., 1992). As transmembrane channels of ABC-2-type
transporters are either homo- or heterooligomers and
Rv1456c has features of a transporter protein, it is plau-
sible to suggest that the membrane channel coupled to
the glycosyltransferase might be a heterooligomer made
up of Rv1457c and Rv1456c. In a previous study, Wang
et al. (2006) proposed that one or more of the proteins
encoded by the orthologues of Rv1456c-Rv1459c gene
locus in C. matruchotii was involved in mycolic acid
transport. A transposon mutant with an insertion in the
cluster had an altered mycolic acid proﬁle. However, in
light of the evidence described in this work, this change in
mycolylation may be an indirect effect as a result of the
loss of Cg-LAM and Cg-LM-A/B. Further examination of
this gene locus is required for characterization of potential
roles in mycolic acid and glycolipid transport across the
membrane bilayer.
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Bacterial strains and growth conditions
Corynebacterium glutamicum ATCC 13032 (referred to the
remainder of the text as C. glutamicum) and E. coli DH5amcr
were grown in Luria–Bertani broth (Difco) at 30°C and 37°C
respectively. The recombinant strains generated in this study
were grown on rich BHI medium (Difco), and the salt medium
CGXII used for C. glutamicum as described (Eggeling and
Bott, 2005). Kanamycin and ampicillin were used at a con-
centration of 50 mgm l
-1. Samples for lipid analysis were pre-
pared by harvesting cells at an OD of 10–15, followed by a
saline wash and freeze drying. M. smegmatis strains were
grown in Tryptic Soy Broth (TSB; Difco) containing 0.05%
Tween80 (TSBT). Solid media were made by adding 1.5%
agar to the above-mentioned broths. The concentrations of
antibiotics used for M. smegmatis were 100 mgm l
-1 for hygro-
mycin and 20 mgm l
-1 for kanamycin. M. tuberculosis H37Rv
DNA was obtained from the NIH Tuberculosis Research
Materials and Vaccine Testing Contract at Colorado State
University. All other chemicals were of reagent grade and
obtained from Sigma-Aldrich.
Construction of plasmids and strains
The genes analysed were the orthologues of Rv1459c and
NCgl1505 from M. tuberculosis and C. glutamicum, respec-
tively,termedmptB.ThevectorsmadewerepVWEx-Mt-mptB,
pVWEx-Ms-mptB, pVWEx-Cg-mptB, pET-Mt-mptB, pET-Cg-
mptB and pK19mobsacBDmptB. To construct the deletion
vector pK19mobsacBDmptB, cross-over PCR was applied
with primer pairsAB (A, CGTTAAGCTTCCAAAGGTAACCTT
ATTTATGCTGGCCACAGG; B, CCCATCCACTAAACTTAAA
CACGATGCGCGGCAAAGT) and CD (C, TGTTTAAGTTT
AGTGGATGGGGAGTTTGAGGCGGAATCC; D, GCATGGA
TCCGCGGTAAAACCTTCGCACATTTCAATG) (all primers
in 5′-3′ direction) and C. glutamicum genomic DNA as tem-
plate.BothampliﬁedproductswereusedinasecondPCRwith
primer pairs AD to generate a 597 bp fragment consisting
of sequences adjacent to Cg-mptB, which was ligated with
HindIII-BamHI-cleaved pK19mobsacB.
To enable expression of Cg-mptB in C. glutamicum, the
primer pair EF was used (E, CGAATTGGATCCTCAGTGTA
AACCAAAGGTTGGATTCC; F, GATATGTTAACAGGGAGA
TATAGTTGCCGCGCATCGG) to amplify C. glutamicum
mptB, which was ligated with SalI-, BamHI-cleaved pVWEx to
generate pVWEx-Cg-mptB. For expression of Cg-mptB in
E. coli, the primer pair GF was used (G, CGCGTCATATGT
TGCCGCGCATCGGCAC) and the resulting product ligated
with NdeI-, BamHI-cleaved pET16b (Novagen) to gener-
ate pET-Cg-mptB. To enable expression of Mt-mptB in
C. glutamicum, the primer pair HJ was used (H, GATATGT
TAACAGGGAGATATAGATGGCAGCCCGCCAC; J, GGAAT
TGGATCCTCACGTGGAATCAGCGTAGGCG) to amplify M.
tuberculosis mptB, which was ligated with SalI-, BamHI-
cleaved pVWEx to generate pVWEx-Mt-mptB. To express
Mt-mptB in E. coli, the primer pair JK (K, CTTAATGGATC
CATGGCAGCCCGCCAC) was used and the resulting
product ligated with BamHI-cleaved pET16b to generate
pET-Mt-mptB. To enable expression of Ms-mptB in
C. glutamicum, the primer pair MsB_for (5′-CGCGTCGA
CAAGGAGATATAGATATGATGGCCAGCCGCCTGTCGT-3′)
and MsB_rev (5′-CCGGAATTCTTACGGGGATTCAGCGTA
GGCGTC-3′) was used to amplify Ms-mptB, which was
cloned in pUC18 and ligated as an EcoRI/SalI fragment with
similar cleaved pEKEx2 to generate pEKEx2-Ms-mptB.
All plasmids were conﬁrmed by sequencing. The chromo-
somal deletion of Cg-mptB was performed as described
previously using two rounds of positive selection (Schafer
et al., 1994), and its successful deletion was veriﬁed by use
of primer pair AB and the additional primer pair LM
(L, GCGCGTATCACCGTCTCCGGTGTG; M, GCTGTTGGC
CACCTGACAGACGTCG). Because of the similarity of
MptB with MptA, C. glutamicumDmptB was transformed
together with pK19mobsacBDmptA (Mishra et al., 2007) to
yield the double mutant C. glutamicumDmptBDmptA. Plas-
mids pVWEx-Mt-mptB, pVWEx-Ms-mptB and pVWEx-
Cg-mptB were introduced into C. glutamicumDmptB and
C. glutamicumDmptBDmptA by electroporation with selec-
tion to kanamycin resistance (25 mgm l
-1).
To generate an allelic recombination substrate to replace
MSMEG3120 with hyg, approximately 1 kb of upstream and
downstream ﬂanking sequences were PCR-ampliﬁed from M.
smegmatis mc
2155 genomic DNA using the primer pairs
MS3120LL (ttt-ttt-ttc-cat-aaa-ttg gAT-TGT-GAC-GGA-ATT-
CGT-CCG-ACG-GT) and MS3120LR (ttt-ttt-ttc-cat-ttc-ttg-gAT
GCC-CTG-ACC-GAT-CCA-CAG-GAA), and MS3120RL (ttt-
ttt-ttc-cat-aga-ttg-gTG-TTC-CAG-ATC-GTC-ATG-GCA-ACC-
CT) and MS3120RR (ttt-ttt-ttc-cat-ctt-ttg-gAT-GAT-CAC-GAT-
GCG-ATC-GGC-GAG-TT) respectively. The PCR products
consisted of a 682 bp upstream DNA fragment (including the
last 15 bp coding sequence of MSMEG3121, 89 bp inter-
genic sequence and the ﬁrst 578 bp of MSMEG3120) and a
813 bp downstream DNA fragment (including the last 160 bp
of MSMEG3120 and the ﬁrst 655 bp of MEMEG3119). Fol-
lowing restriction digestion of the primer-introduced Van91I
sites (shown in lower case), the PCR fragments were cloned
into Van91I-digested p0004S to yield the knockout plasmid
pDMSMEG3120 which was then packaged into the
temperature-sensitive mycobacteriophage phAE159 as
described previously (Bardarov et al., 2002), to create a
recombinant phage, which was then used to transduce wild-
type M. smegmatis mc
2155 to generate the DMSMEG3120
deletion mutant which was conﬁrmed by Southern blot and
PCR analysis (data not shown).
Lipid extraction and analysis
Polar lipids and apolar lipids were extracted as described
previously (Dobson et al., 1985). Brieﬂy, 6 g of dried cells
of wild-type, mutant and complemented strains of C.
glutamicum or M. smegmatis were mixed thoroughly using
the biphasic mixture of methanolic saline (220 ml containing
20 ml of 0.3% NaCl and 200 ml of CH3OH) and petroleum
ether (220 ml) for 2 h. The upper petroleum-ether layer con-
taining apolar lipids were separated following centrifugation.
The lower methanolic saline extract was further extracted
using petroleum ether (220 ml), mixed and centrifuged. The
two upper petroleum-ether fractions were combined and
dried. Polar lipids were extracted by the addition of CHCl3/
CH3OH/0.3% NaCl (260 ml, 9:10:3, v/v/v) added to the lower
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ﬁltered and the ﬁlter cake re-extracted twice with CHCl3/
CH3OH/0.3% NaCl (85 ml, 5:10:4, v/v/v). CHCl3 (145 ml) and
0.3% NaCl (145 ml) were added to the combined ﬁltrates
and stirred for 1 h. The mixture was allowed to settle, and
the lower layer containing the polar lipids recovered and
dried. The polar lipid extract was examined by 2D-TLC on
aluminum-backed plates of silica gel 60 F254 (Merck 5554),
using CHCl3/CH3OH/H2O (60:30:6, v/v/v) in the ﬁrst direction
and CHCl3/CH3COOH/CH3OH/H2O (40:25:3:6, v/v/v/v) in the
second direction. C. glutamicum glycolipids were visualized
by either spraying plates with a-naphthol/sulphuric acid or 5%
ethanolic molybdophosphoric acid followed by gentle char-
ring of plates. Identiﬁcation of phospholipids was carried out
using the Dittmer and Lester reagent as described (Tatituri
et al., 2007).
Extraction and puriﬁcation of lipoglycans
Lipoglycans from C. glutamicum and M. smegmatis strains
were extracted as described previously (Nigou et al., 1997;
Ludwiczak et al., 2002). Brieﬂy, delipidated cells were
re-suspended in deionized water and disrupted by probe
sonication (MSE Soniprep 150, 12 mm amplitude, 60 s on,
90 s off for 10 cycles, on ice). Ethanol extraction was carried
out by mixing C2H5OH/H2O (100 ml, 1:1, v/v) to the cell sus-
pension and reﬂuxing at 68°C, for 12 h intervals, followed by
centrifugation and recovery of the supernatant. This C2H5OH/
H2O extraction process was repeated ﬁve times and the
combined supernatants dried. The dried supernatant was
then treated with phenol/H2O (80%, w/w) at 70°C for 1 h
followed by dialysis using a 1500 MWCO membrane (Spec-
trapore) against deionized water. The retentate was dried,
re-suspended in water and treated sequentially digested with
a-amylase, DNase, RNase chymotrypsin and trypsin, and the
lipoglycan recovered following extensive dialysis using a
1500 MWCO membrane (Spectrapore) against deionized
water (Nigou et al., 1999). The lipoglycans were monitored on
15% SDS-PAGE using either a silver stain utilizing periodic
acid and silver nitrate (Hunter et al., 1986) or a Pro-Q
emerald glycoprotein stain (Invitrogen).
Extraction and analysis of [14C]PIMs from
M. smegmatis strains
Mycobacterium smegmatis cultures (5 ml) were grown in TSB
and metabolically labelled using 1 mCi ml
-1 [1,2-
14C]acetate
(50–62 mCi mmol
-1, GE Healthcare, Amersham Bioscience)
at an OD600 of 0.4 and cultures grown for a further 4 h at
37°C with gentle shaking. Cells were harvested by centrifu-
gation, washed once with PBS and a small-scale apolar and
polar lipid extraction performed according to the methods
of Dobson et al. (1985). The polar lipid extracts were
re-suspended in CHCl3:CH3OH (2:1) and crude lipid
(50 000 c.p.m.) applied to the corners of 6.6 ¥ 6.6 cm pieces
of Merck 5554 aluminium-backed TLC plates. The plates
were developed using CHCl3:CH3OH:H2O (60:30:6, v/v/v)
in the ﬁrst direction and CHCl3:CH3COOH:CH3OH:H2O
(40:25:3:6, v/v/v/v) in the second direction to separate [
14C]-
labelled PIMs. Lipids were visualized by autoradiography by
overnight exposure of Kodak X-Omat AR ﬁlm to the TLC
plates to reveal labelled lipids and compared with known
standards.
Preparation of enzymatically active membranes and
cell envelope fraction
Mycobacterium smegmatis and C. glutamicum strains used
in this study were cultured to the mid-logarithmic growth
phase in 1 l BHIS medium supplemented with kanamycin
(25 mgm l
-1) and IPTG (0.2 mM) where appropriate. Cells
were harvested by centrifugation, re-suspended in 20 ml of
bufferA(50 mM MOPS pH 7.9, 5 mM b-mercaptoethanol and
5 mM MgCl2) and lysed immediately by sonication (60 s on,
90 s off for a total of 10 cycles). The lysate was clariﬁed by
centrifugation at 27 000 g (4°C, 30 min) and membranes
were deposited by centrifugation of the supernatant at
100 000 g (4°C, 90 min). The membranes were re-
suspended in buffer A to a ﬁnal protein concentration of
20 mg ml
-1. The 27 000 g pellet was re-suspended in 10 ml of
buffer A and 15 ml of Percoll (Pharmacia, Sweden), and
centrifuged at 27 000 g for 60 min at 4°C. The particulate,
upper diffuse band, containing both cell walls and mem-
branes, was removed, collected by centrifugation, washed
three times in buffer A, and ﬁnally re-suspended in 1 ml of
buffer A. The ﬁnal concentration of this Percoll-60 cell enve-
lope fraction (P-60) was 20 mg ml
-1.
In vitro incorporation of radiolabelled Man from
GDP-[14C]Man into membrane lipids
Initial assays involved incubation of membranes (0.5 mg of
protein), P-60 fraction (0.5 mg of protein) in buffer A, contain-
ing 1 mM ATP and 0.25 mCi of GDP-[
14C]Man (Amersham
Pharmica Biotech, Uppsala, Sweden, 303 mCi mmol
-1)i na
ﬁnal volume of 100 ml incubated at 37°C for 60 min as
described (Besra et al., 1997). The reactions were terminated
by the addition of CHCl3/CH3OH (6 ml, 2:1, v/v), centrifuged
and the pellet re-extracted thrice using CHCl3/CH3OH (6 ml,
2:1, v/v). The resulting insoluble pellet was sequentially
washed three times with 0.9% NaCl in CH3OH (2 ml), CH3OH/
H2O (2 ml, 1:1, v/v) and CH3OH (2 ml) to remove residual
GDP-[
14C]Man before extracting three times with CHCl3/
CH3OH/H2O (2 ml, 10:10:3, v/v/v). The CHCl3/CH3OH/H2O
(10:10:3)-soluble lipids were dried and re-suspended in
200 ml of CHCl3/CH3OH/H2O (10:10:3, v/v/v) and an aliquot
(10%) of the resulting [
14C]-labelled mannooligosaccharide
polymers [a(1→6)-linear-LM-A and a(1→6)-linear-LM-B]
quantiﬁed by liquid scintillation counting using 5 ml of EcoS-
cintA (National Diagnostics, Atlanta, GA). The remaining
aliquot was analysed by SDS-PAGE/autoradiography. The
original combined CHCl3/CH3OH (2:1) organic extracts were
dried and re-suspended in CHCl3/CH3OH/H2O (4 ml, 10:10:3,
v/v/v) followed by the addition of 1.75 ml of CHCl3 (1.75 ml)
and H2O (0.75 ml). The reaction mixture was vortexed, cen-
trifuged and the upper aqueous phase removed. The organic
phase was washed three times with CHCl3/CH3OH/H2O (2 ml,
3:47:48, v/v/v), and the ﬁnal organic extract dried under a
stream of nitrogen to afford C50-PP[
14C]M, Ac1PI[
14C]M2 and
[
14C]Man1GlcAGroAc2. Alternatively, the combined CHCl3/
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in CHCl3/CH3OH/0.8 M NaOH (4 ml, 10:10:3, v/v/v) and
heated at 50°C for 30 min, followed by the addition of CHCl3
(1.75 ml) and H2O (0.75 ml), and processed as described
above to afford C50-PP[
14C]M. The resulting C50-PP[
14C]M,
Ac1PI[
14C]M2 and [
14C]Man1GlcAGroAc2 products were
subjected to TLC/autoradiography using silica gel plates
(5735 silca gel 60F254, Merck) developed in CHCl3:
CH3OH:H2O:NH4OH (65:25:3.6:0.5, v/v/v/v) and the products
visualized and quantiﬁed by phosphorimaging (Kodak K
Screen).
Pre-treatment of membranes with amphomycin and
further incorporation of in situ labelled [14C]Man-labelled
membrane glycolipids into CHCl3/CH3OH/H2O (10:10:3)-
soluble [14C]-labelled mannooligosaccharide polymers
The lipopetide amphomycin (2 mg) was dissolved in 500 mlo f
0.1 M acetic acid, and the solution adjusted to 0.05 M sodium
acetate (pH 7.0) with 0.1 M NaOH for a ﬁnal concentration of
2m gm l
-1 (Gurcha et al., 2002). Membranes/cell envelope
(5 mg) in 500 ml of buffer A were pre-incubated with ampho-
mycin (10 mg per 100 ml reaction mixture) at 37°C for 15 min,
resulting in inhibition of PPM synthesis, prior to a further short
15 min pulse incubation with 1.25 mCi of GDP-[
14C]Man
(Amersham Pharmica Biotech, Uppsala, Sweden,
303 mCi mmol
-1). A 20% aliquot of the reaction mixture was
processed as described above to afford Ac1PI[
14C]M2,
[
14C]Man1GlcAGroAc2 and CHCl3/CH3OH/H2O (10:10:3)-
soluble lipids. The remaining amphomycin-treated
membranes/cell envelope containing in situ [
14C]Man-labelled
lipids (Ac1PIM2 and Man1GlcAGroAc2) were diluted with buffer
A and recovered by re-centrifugation at 100 000 g for 60 min,
carefully washed and re-centrifuged with cold buffer A twice,
thereby ensuring complete removing of unused GDP-
[
14C]Man (Besra et al., 1997). The [
14C]Man-labelled mem-
branes were then carefully re-suspended in 400 ml buffer A
prior to the addition of 0.5 mg C50-PPM in 1% IgePal CA-630
(40 ml, SigmaAldrich) (Gurcha et al., 2002), incubated further
at 37°C for 60 min and a 100 ml aliquot processed/analysed
as described above to provide the CHCl3/CH3OH (2:1) and
CHCl3/CH3OH/H2O (10:10:3)-soluble [
14C]-labelled mannose-
containing products.
In vitro analysis of a(1,6) mannosyltransferase activity
The neoglycolipid acceptors a-D-Manp-(1→6)-a-D-Manp-
O-C8 (stored in C2H5OH) and C50-PP[
14C]M (stored in CHCl3/
CH3OH, 2:1, v/v), prepared as described (Gurcha et al.,
2002), were separated into aliquots into 1.5 ml eppendorf
tubes to a ﬁnal concentration of 2 mM and 0.25 mCi
(0.305 Ci mmol
-1) respectively, and dried under nitrogen.
IgePal CA-630 (8 ml, SigmaAldrich) was added and the tubes
sonicated to re-suspend the lipid-linked components, and the
remaining assay components in a ﬁnal volume of 80 ml were
added, which included: 1 mM ATP, 1 mM NADP, and
membrane protein (1 mg) from either C. glutamicum, C. glut-
amicumDmptB, C. glutamicumDmptA, C. glutamicumDmptB
pVWEx-Cg-mptB, C. glutamicumDmptBDmptA, C. glutamic-
umDmptBDmptA pVWEx-Cg-mptB, C. glutamicumDmptBD-
mptA pVWEx-Cg-mptA, C. glutamicumDmptBDmptA pVWEx-
Mt-mptB and C. glutamicumDmptBDmptA pVWEx-Ms-mptB.
Assays were incubated at 37°C for 1 h and then quenched by
the addition of CHCl3/CH3OH (533 ml, 1:1, v/v). The reaction
mixtures were then centrifuged at 27 000 g for 15 min at 4°C,
the supernatant removed and dried under nitrogen. The
residue was re-suspended in C2H5OH/H2O (700 ml, 1:1, v/v)
and loaded onto a 1 ml SepPak strong anion exchange car-
tridge (Supleco) pre-equilibrated with C2H5OH/H2O (1:1, v/v).
The column was washed with 2 ml of C2H5OH, and the eluate
collected, dried and partitioned between the two phases
arising from a mixture of n-butanol (3 ml) and water (3 ml).
The resulting organic phase was recovered after centrifuga-
tion at 3500 g, and the aqueous phase again extracted twice
with 3 ml of water-saturated butanol. The pooled extracts
were back-washed twice with n-butanol-saturated water
(3 ml). The n-butanol fraction was dried and re-suspended in
200 mlo fn-butanol. The extracted radiolabelled material was
quantiﬁed by liquid scintillation counting using 10% of the
labelled material and 5 ml of EcoScintA (National Diagnos-
tics, Atlanta, GA). The incorporation of [
14C]Manp was deter-
mined by subtracting counts present in control assays
(incubations in the absence of acceptor), which were typically
less than 100 c.p.m. per assay. The remaining labelled mate-
rial was subjected to TLC using silica gel plates (5735 silca
gel 60F254, Merck) developed in CHCl3:CH3OH:H2O:NH4OH
(65:25:3.6:0.5, v/v/v/v) and the products visualized by phos-
phorimaging (Kodak K Screen).
Selective cleavage by partial acetolysis
[
14C]-mannosylated products were dried and acetylated using
40 ml of pyridine/acetic anhydride (1:1, v/v) for 30 min at
100°C. The products were dried in a Speed Vac and residual
acetic acid removed by co-evaporation with toluene
(2 ¥ 50 ml). The per-O-acetylated products were dissolved in
30 ml of acetic anhydride/acetic acid/sulphuric acid (10:10:1,
v/v/v) and acetolysis performed for 8 h at 37°C (Brown et al.,
1997). The reaction mixture was then quenched by the addi-
tion of 10 ml pyridine and 500 mlH 2O. After 1 h, the per-O-
acetylated products were recovered by extraction into CHCl3.
The CHCl3 phase was washed three times with 500 mlo fH 2O
and dried. The products were then de-O-acetylated using
200 ml of concentrated ammonium hydroxide/methanol (1:1,
v/v) for 60 h at 37°C and subsequently dried. The acetolysis
products derived from a-D-[
14C]Manp-(1→6)-a-D-Manp-
(1→6)-a-D-Manp-O-C8 were re-dissolved in 40% propan-1-ol
and analysed by TLC using one development with propan-1-
ol/acetone/H2O (5:4:1, v/v/v), followed by one development
with butan-1-ol/acetone/H2O (5:3.5:1.5, v/v/v) and the prod-
ucts visualized by phosphorimaging (Kodak K Screen). The
acetolysis products derived from the CHCl3/CH3OH/H2O
(10:10:3)-soluble [
14C]-labelled mannooligosaccharide
polymer [a(1→6)-linear-LM-A and a(1→6)-linear-LM-B] were
re-dissolved in water and applied onto a 50 ml Bio-Gel P-2
gel ﬁltration column (30 ¥ 1.5 cm; Bio-Rad). Elution from the
column was performed using water and 1 ml fractions
collected which were subsequently quantiﬁed by liquid scin-
tillation counting. The control de-O-acylated [
14C]-labelled
mannooligosaccharide polymers prior to acetolysis eluted
form the Bio-Gel P-2 column at fractions 11–13 and degraded
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fractions 33–39 based on a de-O-acylated PI[
14C]M2,
[
14C]Man1GlcAGroAc2 and [
14C]Man standards.
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